Brief: Aytu Biopharma Says Quarterly Net Revenue Increased 74% Sequentially To $23.5 Million
27/09/2021 22:52
Sept 27 (Reuters) - Aytu Biopharma Inc AYTU.O :
* AYTU BIOPHARMA INC - QUARTERLY NET REVENUE INCREASED 74%
SEQUENTIALLY TO $23.5 MILLION
* AYTU BIOPHARMA INC - NET LOSS FOR Q4 $0.81 PER SHARE
Source text for Eikon: ID:
Further company coverage: AYTU.O
Recent news on Aytu Biopharma
See all newsAytu Biopharma Inc reports results for the quarter ended March 31 - Earnings Summary
Aytu BioPharma Q4 revenue beats analyst estimates on EXXUA sales
Aytu Biopharma Inc expected to post a loss of 32 cents a share - Earnings Preview
Aytu BioPharma Q3 revenue falls amid EXXUA launch
Aytu BioPharma Q2 revenue beats expectations